Lisdexamfetamine 50 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DB26FATZE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,201
Award facts
- Contract value 100% obligated
- $2,201.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,201.43 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Lisdexamfetamine 50 mg capsules (90-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and performance will be executed in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating that DMS Pharmaceutical Group competed in an unrestricted procurement environment. This delivery order was issued under the company's Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group Inc., headquartered in Park Ridge, Illinois, has maintained active registration in the System for Award Management since 2001 and serves as a critical supplier within the federal pharmaceutical supply chain. The company's portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. As one of multiple regional prime vendor contractors under the PPV-G GEN V program, DMS Pharmaceutical Group holds a single-award IDC with a ceiling value of $499,999,999 and completion date of December 31, 2036, positioning the firm to fulfill the diverse and specialized pharmaceutical requirements of the military medical system across multiple therapeutic categories and geographic regions.
Quick answers
Who was awarded contract SPE2DB26FATZE?
SPE2DB26FATZE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZE worth?
The government has obligated $2,201 on SPE2DB26FATZE.
Is contract SPE2DB26FATZE an order under another contract?
Yes. SPE2DB26FATZE is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZE competed?
The extent of competition for SPE2DB26FATZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award